2011 St Gallen Consensus breast cancer recommendations

Prof Richard Gelber - Dana-Farber Cancer Institute, Boston, USA; Prof Aron Goldhirsch – European Institute of Oncology, Milan
2011 St Gallen Consensus breast cancer recommendations ( Prof Richard Gelber - Dana-Farber Cancer Institute, Boston, USA; Prof Aron Goldhirsch – European Institute of Oncology, Milan )
25 Oct 2011

Advances in the prevention of cervical cancer

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Advances in the prevention of cervical cancer ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
21 Oct 2011

Synchronous chemoradiation significantly reduces the risk of the breast cancer recurrence

Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK
Synchronous chemoradiation significantly reduces the risk of the breast cancer recurrence ( Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK )
20 Oct 2011

Use of circulating tumour cells as a prognostic or predictive marker

Prof Caroline Dive - Paterson Institute for Cancer Research, Manchester, UK
Use of circulating tumour cells as a prognostic or predictive marker ( Prof Caroline Dive - Paterson Institute for Cancer Research, Manchester, UK )
20 Oct 2011

Recent advances in advanced breast cancer

Prof Stephen Johnston; Prof Johanna Mattson; Prof Ahmad Awada; Prof Rob Coleman
Recent advances in advanced breast cancer ( Prof Stephen Johnston; Prof Johanna Mattson; Prof Ahmad Awada; Prof Rob Coleman )
18 Oct 2011

Cell of origin of ovarian cancer

Prof Louis Dubeau - University of Southern California, Los Angeles, USA
Cell of origin of ovarian cancer ( Prof Louis Dubeau - University of Southern California, Los Angeles, USA )
18 Oct 2011

Multi-centre male breast cancer study

Dr Laura Ottini – University of Rome La Sapienza, Italy
Multi-centre male breast cancer study ( Dr Laura Ottini – University of Rome La Sapienza, Italy )
18 Oct 2011

History and highlights of HBOC; understanding the genome and raising awareness

Prof Franco Muggia – New York University Medical Center, USA
History and highlights of HBOC; understanding the genome and raising awareness ( Prof Franco Muggia – New York University Medical Center, USA )
18 Oct 2011

Magnetic resonance imaging: advancements and benefits of use in screening

Prof Francesco Sardanelli – University of Milan, Italy
Magnetic resonance imaging: advancements and benefits of use in screening ( Prof Francesco Sardanelli – University of Milan, Italy )
17 Oct 2011

Understanding genetic predisposition to cancer

Dr Ellen Warner – Odette Cancer Center, Toronto, Canada
Understanding genetic predisposition to cancer ( Dr Ellen Warner – Odette Cancer Center, Toronto, Canada )
17 Oct 2011

Cancer risk communication

Carol Maddock - Cancer Communications Researcher, Tenovus
Cancer risk communication ( Carol Maddock - Cancer Communications Researcher, Tenovus )
17 Oct 2011

Symmetrical and asymmetrical stem cell proliferation

Dr Wenjun Guo – Whitehead Institute for Biomedical Research, Cambridge, USA
Symmetrical and asymmetrical stem cell proliferation ( Dr Wenjun Guo – Whitehead Institute for Biomedical Research, Cambridge, USA )
17 Oct 2011